what bmi qualifies for tirzepatide weight loss eligibility and benefits Who is a Candidate for

In a post hoc analysis of the SURPASS-4 trial in people with type 2 diabetes and high CV risk, the first-in-class dual GIP/GLP-1 RA tirzepatide was found to reduce albuminuria and slow the rate of eGFR decline compared to insulin glargine (Heerspink et al, 2022)

Because retatrutide is not yet approved, its full safety profile in diverse, real-world populations is not yet established

This transparent pricing model removes financial barriers to dose optimization, ensuring cost never interferes with finding your optimal therapeutic level

Melanin is a naturally occurring pigment that is produced by specialised skin cells known as melanocytes